Anxiety and depression in cystic fibrosis

Seminars in Respiratory and Critical Care Medicine

Volumn 30, Issue 5, 2009, Pages 569-578

  Cruz, Ivette ^a   Marciel, Kristen K ^a   Quittner, Alexandra L ^a   Schechter, Michael S ^b,c  

^a UNIVERSITY OF MIAMI   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

Adherence; Anxiety; Cystic fibrosis; Depression; Psychological interventions

Indexed keywords

BENZODIAZEPINE DERIVATIVE; MIRTAZAPINE; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ANXIETY DISORDER; COGNITIVE THERAPY; COMORBIDITY; COMPREHENSION; CYSTIC FIBROSIS; DYSTHYMIA; HEALTH; HUMAN; INFORMATION; LIFESPAN; MAJOR DEPRESSION; OUTCOME ASSESSMENT; POPULATION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCREENING; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY; CHILD; CYSTIC FIBROSIS; DEPRESSION; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; PREVALENCE; QUALITY OF LIFE; YOUNG ADULT;

EID: 70350443766     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0029-1238915     Document Type: Review

References (110)

1. Wells K B., Golding J M., Burnam M A. Chronic medical conditions in a sample of the general population with anxiety, affective, and substance use disorders. Am J Psychiatry 1989 146 1440-1446
2. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 1997 42 17-41
3. Riolo S A., Nguyen T A., Greden J F., King C A. Prevalence of depression by race/ethnicity: findings from the National Health and Nutrition Examination Survey III. Am J Public Health 2005 95 998-1000
4. Roy-Byrne P P., Davidson K W., Kessler R C. et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008 30 208-225
5. DiMatteo M R., Lepper H S., Croghan T W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000 160 2101-2107
6. Gorman J M. Comorbid depression and anxiety spectrum disorders. Depress Anxiety 1996-1997 4 160-168
7. Katon W, Ciechanowski P. Impact of major depression on chronic medical illness. J Psychosom Res 2002 53 859-863
8. Sherbourne C D., Wells K B., Meredith L S., Jackson C A., Camp P. Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psychiatry 1996 53 889-895
9. Dowson C A., Kuijer R G., Mulder R T. Anxiety and self-management behavior in chronic obstructive pulmonary disease: what has been learned? Chron Respir Dis 2004 1 213-220
10. Whittemore R, Kanner S, Singleton S, Hamrin V, Chiu J, Grey M. Correlates of depressive symptoms in adolescents with type 1 diabetes. Pediatr Diabetes 2002 3 135-143 (Pubitemid 35203520)
11. Cystic Fibrosis Foundation. Patient Registry 2006 Annual Report. Bethesda, MD Cystic Fibrosis Foundation 2008
12. Quittner A L., Barker D H., Marciel K K., Grimley M E. Cystic fibrosis: a model for drug discovery and patient care In: Roberts MC, Steele RG Handbook of Pediatric Psychology. New York, NY Guilford Press 2009 271-286
13. Quittner A L., Barker D H., Snell C, Grimley M E., Marciel K, Cruz I. Prevalence and impact of depression in cystic fibrosis. Curr Opin Pulm Med 2008 14 582-588
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text rev. Washington, DC American Psychiatric Association 2000
15. Chorpita B F., Daleiden E L., Moffitt C, Yim L, Umemoto L A. Assessment of tripartite factors of emotion in children and adolescents, I: Structural validity and normative data of an affect and arousal scale. J Psychopathol Behav Assess 2000 22 141-160
16. Daleiden E, Chorpita B F., Lu W. Assessment of tripartite factors of emotion in children and adolescents: II. Concurrent validity of the affect and arousal scales for children. J Psychopathol Behav Assess 2000 22 161-182 (Pubitemid 30456991)
17. Weems C F., Costa N M., Watts S E., Taylor L K., Cannon M F. Cognitive errors, anxiety sensitivity, and anxiety control beliefs: their unique and specific associations with childhood anxiety symptoms. Behav Modif 2007 31 174-201
18. Weems C F., Silverman W K., Rapee R R., Pina A A. The role of control in childhood anxiety disorders. Cognit Ther Res 2003 27 557-568
19. Ollendick T H. Reliability and validity of the Revised Fear Survey Schedule for Children (FSSC-R). Behav Res Ther 1983 21 685-692
20. Burnham J J., Gullone E. The Fear Survey Schedule for Children, II: A psychometric investigation with American data. Behav Res Ther 1997 35 165-173
21. Zigmond A S., Snaith R P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 67 361-370
22. March J S., Parker J DA, Sullivan K, Stallings P, Conners C K. The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry 1997 36 554-565
23. March J S., Sullivan K, James P. Testretest reliability of the multidimensional anxiety scale for children. J Anxiety Disord 1999 13 349-358
24. Chorpita B F., Tracey S A., Brown T A., Collica T J., Barlow D H. Assessment of worry in children and adolescents: an adaptation of the Penn State Worry Questionnaire. Behav Res Ther 1997 35 569-581
25. Chorpita B F., Moffitt C E., Gray J. Psychometric properties of the Revised Child Anxiety and Depression Scale in a clinical sample. Behav Res Ther 2005 43s 309-322
26. Chorpita B F., Yim L, Moffitt C, Umemoto L A., Francis S E. Assessment of symptoms of DSM-IV anxiety and depression in children: a revised child anxiety and depression scale. Behav Res Ther 2000 38 835-855
27. Reynolds C R., Richmond B O. Revised Children's Manifest Anxiety Scale: Manual. Los Angeles Western Psychological Services 1985
28. Birmaher B, Khetarpal S, Brent D A. et al. The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry 1997 36 545-553
29. Spence S H. A measure of anxiety symptoms among children. Behav Res Ther 1998 36 545-566
30. Spielberger C D. Manual for the State-Trait Anxiety Inventory for Children. Palo Alto Consulting Psychologists Press 1973
31. Lowe P A. Common and Uncommon Manifestations of Anxiety across the Life Span. Ph.D. diss. College Station Texas A&M University 2000
32. Reynolds C R., Richmond B O., Lowe P A. The Adult Manifest Anxiety Scale: Manual. Los Angeles Western Psychological Services 2003
33. Fydrich T, Dowdall D, Chambless D L. Reliability and validity of the Beck Anxiety Inventory. J Anxiety Disord 1992 6 55-61
34. Osman A, Kopper B A., Barrios F X., Osman J R., Wade T. The Beck Anxiety Inventory: reexamination of factor structure and psychometric properties. J Clin Psychol 1997 53 7-14 (Pubitemid 27026938)
35. Van Zuuren F J. The fear questionnaire: some data on validity, reliability and layout. Br J Psychiatry 1988 153 659-662
36. Reynolds W M. Multidimensional Anxiety Questionnaire. Lutz, FL Psychological Assessment Resources, Inc. 2003
37. Meyer T J., Miller M L., Metzger R L., Borkovec T D. Development and validation of the Penn State worry questionnaire. Behav Res Ther 1990 28 487-495
38. Barnes L LB, Harp D, Jung W S. Reliability generalization of scores on the Spielberger State-Trait Anxiety Inventory. Educ Psychol Meas 2002 62 603-618
39. Spielberger C D., Gorsuch R L., Lushene R E. Manual for the State-Trait Anxiety Inventory. Palo Alto Consulting Psychologists Press 1970
40. Holmbeck G N., Thill A W., Bachanas P et al. Evidence-based assessment in pediatric psychology: Measures of psychosocial adjustment and psychopathology. J Pediatr Psychol 2008 33 958-980 discussion 981-982
41. Silverman W K., Ollendick T H. Evidence-based assessment of anxiety and its disorders in children and adolescents. J Clin Child Adolesc Psychol 2005 34 380-411
42. Costello E J., Egger H, Angold A. 10-year research update review: The epidemiology of child and adolescent psychiatric disorders, I: Methods and public health burden. J Am Acad Child Adolesc Psychiatry 2005 44 972-986
43. Southam-Gerow M A., Chorpita B F. Anxiety in children and adolescents In: Mash EJ, Barkley RA Assessment of Childhood Disorders. New York Guilford Press 2007 347-397
44. Costello E J., Costello A J., Edelbrock C et al. Psychiatric disorders in pediatric primary care: prevalence and risk factors. Arch Gen Psychiatry 1988 45 1107-1116
45. Cartwright-Hatton S, McNicol K, Doubleday E. Anxiety in a neglected population: prevalence of anxiety disorders in pre-adolescent children. Clin Psychol Rev 2006 26 817-833
46. Dantzer C, Swendsen J, Maurice-Tison S, Salamon R. Anxiety and depression in juvenile diabetes: a critical review. Clin Psychol Rev 2003 23 787-800
47. Szajnberg N, Krall V, Davis P, Treem W, Hyams J. Psychopathology and relationship measures in children with inflammatory bowel disease and their parents. Child Psychiatry Hum Dev 1993 23 215-232
48. Albano A M., Chorpita B F., Barlow D H. Childhood anxiety disorders In: Mash EJ, Barkley RA Child Psychopathology. New York Guilford 2003 279-329
49. Essau C A., Conradt J, Petermann F. Frequency, comorbidity, and psychosocial impairment of specific phobia in adolescents. J Clin Child Psychol 2000 29 221-231
50. Piacentini J, Graae F. Childhood OCD In: Hollander E, Stein D Obsessive-Compulsive Disorders: Etiology, Treatment. New York Marcel Dekker 1997 23-46
51. Goodwin R D., Gotlib I H. Panic attacks and psychopathology among youth. Acta Psychiatr Scand 2004 109 216-221
52. Burke P, Meyer V, Kocoshis S et al. Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis. J Am Acad Child Adolesc Psychiatry 1989 28 948-951 (Pubitemid 20031032)
53. Casier A, Goubert L, Huse D et al. The role of acceptance in psychological functioning in adolescents with cystic fibrosis: a preliminary study. Psychol Health 2008 23 629-638
54. Cepuch G, Debska G, Wordliczek J, Mazurek H. Evaluation of anxiety and depression incidence in adolescents with cystic fibrosis or malignant disease. Advances in Palliative Medicine 2007 6 75-82
55. Pumariega A J., Pearson D A., Seilheimer D K. Family and childhood adjustment in cystic fibrosis. J Child Fam Stud 1993 2 109-118
56. White T, Miller J, Smith G L., McMahon W M. Adherence and psychopathology in children and adolescents with cystic fibrosis. Eur Child Adolesc Psychiatry 2009 18 96-104
57. Hodges K, Kline J, Stern L, Cytryn L, McKnew D. The development of a child assessment interview for research and clinical use. J Abnorm Child Psychol 1982 10 173-189
58. Thompson R J. Jr, Gustafson K E., Gil K M., Godfrey J, Murphy L M. Illness specific patterns of psychological adjustment and cognitive adaptational processes in children with cystic fibrosis and sickle cell disease. J Clin Psychol 1998 54 121-128
59. Besier T, Quittner A L., Goldbeck L. Symptoms of anxiety and depression, pulmonary function and their association with life satisfaction in patients with cystic fibrosis [abstract]. J Cyst Fibros 2008 S7 107
60. Goldbeck L, Quittner A L., Besier T. Anxiety and depression in dyads of adolescents with CF and their caregivers [abstract]. J Cyst Fibros 2008 S7 107
61. Bregnballe V, Thastum M, Schiøtz P O. Psychosocial problems in children with cystic fibrosis. Acta Paediatr 2007 96 58-61
62. Howland R H., Thase M E. Comorbid depression and anxiety: when and how to treat. Journal of Psychiatry 2005 329 891-1047
63. Kroenke K, Spitzer R L., Williams J BW, Monahan P O., Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007 146 317-325
64. Chapman E, Bilton D. Patients knowledge of cystic fibrosis: genetic determinism and implications for treatment. J Genet Couns 2004 13 369-385
65. Delelis G, Christophe V, Leroy S, Vanneste J, Wallaert B. The effects of cystic fibrosis on couples: marital satisfaction, emotions, and coping strategies. Scand J Psychol 2008 49 583-589
66. Pearson D A., Pumariega A J., Seilheimer D K. The development of psychiatric symptomatology in patients with cystic fibrosis. J Am Acad Child Adolesc Psychiatry 1991 30 290-297
67. Anderson D L., Flume P A., Hardy K K. Psychological functioning of adults with cystic fibrosis. Chest 2001 119 1079-1084
68. Havermans T, Colpaert K, Dupont L J. Quality of life in patients with cystic Fibrosis: association with anxiety and depression. J Cyst Fibros 2008 7 581-584
69. Birmaher B, Ryan N D., Williamson D E. Depression in children and adolescents: clinical features and pathogenesis In: Shulman KI, Tohen M, Kutcher SP Mood Disorders across the Life Span. New York Wiley-Liss 1996 51-81
70. Birmaher B, Ryan N D., Williamson D E. et al. Childhood and adolescent depression: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry 1996 35 1427-1439 (Pubitemid 26360928)
71. Costello E J., Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 2003 60 837-844
72. Shaffer D, Fisher P, Dulcan M K. et al. The NIMH Diagnostic Interview Schedule for Children version 2.3 (DISC-2.3): description, acceptability, prevalence rates and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry 1996 35 865-877
73. Substance Abuse and Mental Health Services Administration. Results from the 2004 National Survey on Drug Use and Health: National Findings. NSDUH Series H-28 Rockville, MD Office of Applied Studies 2005
74. Burke P, Elliott M. Depression in pediatric chronic illness: a diathesis-stress model. Psychosomatics 1999 40 5-17
75. Smith B A., Modi A C., Quittner A L., Wood B L. Co-morbidity of depression and cystic fibrosis in children and adolescents: associations with adherence to medical treatment. Under review
76. Egede L E. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry 2007 29 409-416
77. Evans D L., Charney D S., Lewis L et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005 58 175-189
78. Kessler R C., Nelson C B., McGonagle K A., Liu J, Swartz M, Blazer D G. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl 1996 17-30
79. Hirschfeld R MA. The comorbidity of major depression and anxiety disorders: Recognition and management in primary care. Prim Care Companion J Clin Psychiatry 2001 3 244-254
80. Löwe B, Spitzer R L., Williams J BW, Mussell M, Schellberg D, Kroenke K. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry 2008 30 191-199
81. Schechter M S. Non-genetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and healthcare interventions. Semin Respir Crit Care Med 2003 24 639-652
82. Katon W, Lin E H., Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007 29 147-155
83. James A, Soler A, Weatherall R. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev 2005 4 CD004690
84. Riekert K A., Bartlett S J., Boyle M P., Krishnan J A., Rand C S. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007 132 231-237
85. Greer J A., Pirl W F., Park E R., Lynch T J., Temel J S. Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer. J Psychosom Res 2008 65 549-552
86. Luyster F S., Hughes J W., Gunstad J. Depression and anxiety symptoms are associated with reduced dietary adherence in heart failure patients treated with an implantable cardioverter defibrillator. J Cardiovasc Nurs 2009 24 10-17
87. Minkovitz C S., Strobino D, Scharfstein D et al. Maternal depressive symptoms and children's receipt of health care in the first 3 years of life. Pediatrics 2005 115 306-314
88. Smith B A., Wood B L. Psychological factors affecting disease activity in children and adolescents with cystic fibrosis: medical adherence as a mediator. Curr Opin Pediatr 2007 19 553-558
89. Sredl D, Werner T, Springhart D, Watkins D, Shaner M, McBride G. An evidence-based pilot study exploring relationships between psychologic and physiologic factors in post-lung-transplant adolescents with cystic fibrosis. J Pediatr Nurs 2003 18 216-220
90. Quittner A L., Barker D H., Geller D et al. Effects of maternal depression on electronically monitored enzyme adherence and changes in weight for children with CF [abstract]. J Cyst Fibros 2007 S6 77
91. Cully J A., Graham D P., Stanley M A. et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2006 47 312-319
92. Quittner A L., Buu A, Messer M A., Modi A C., Watrous M. Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 2005 128 2347-2354
93. Cipriani A, Brambilla P, Furukawa T et al. Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev 2005 4 CD004185
94. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry 2004 61 714-719
95. Kirkwood C K., Hayes P E. Anxiety disorders In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM Pharmocotherapy: A Pathophysiologic Approach. Stamford Appleton & Lange 2005 1443-1462
96. Sykes R, Kittel F, Marcus M, Tarter E, Schroth M. Mirtazapine for appetite stimulation in children with cystic fibrosis [abstract]. Pediatr Pulmonol 2006 S40 389
97. Bostic J Q., Rubin D H., Prince J, Schlozman S. Treatment of depression in children and adolescents. J Psychiatr Pract 2005 11 141-154
98. US Food and Drug Administration. Worsening depression and suicidality in patients treated with antidepressant medications. 2004. Available at: http://www.fda.gov/cder/drug/antidepressants/AntidepressanstPHA.htm (Accessed May 22, 2008)
99. Deshauer D, Moher D, Fergusson D, Moher E, Sampson M, Grimshaw J. Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials. CMAJ 2008 178 1293-1301
100. de Maat S M., Dekker J, Schoevers R A., de Jonghe F. Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis. Eur Psychiatry 2007 22 1-8
101. Beck A T., Rush A J., Shaw B F., Emery G. Cognitive Therapy of Depression. New York Guilford Press 1979
102. Clark D M., Fairburn C G. Science and Practice of Cognitive Behaviour Therapy. New York Oxford University Press 2005
103. Kapornai K, Vetró A. Depression in children. Curr Opin Psychiatry 2008 21 1-7
104. Weisz J R., McCarty C A., Valeri S M. Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull 2006 132 132-149
105. Cuijpers P, van Straten A, Warmerdam L. Behavioral activation treatments of depression: a meta-analysis. Clin Psychol Rev 2007 27 318-326
106. Duff A JA. Psychological interventions in cystic fibrosis and asthma. Paediatr Respir Rev 2001 2 350-357
107. Caron A, Weissman M M. Interpersonal psychotherapy in the treatment of depression in medical patients. Prim Psychiatry 2006 13 43-50
108. Kilbourne A M., Daugherty B, Pincus H A. What do general medical guidelines say about depression care? Depression treatment recommendations in general medical practice guidelines. Curr Opin Psychiatry 2007 20 626-631
109. Glasscoe C A., Quittner A L. Psychological interventions for people with cystic fibrosis and their families. Cochrane Database Syst Rev 2008 3 CD003148
110. US Preventive Services Task Force. Screening and treatment for major depressive disorder in children and adolescents: US Preventive Services Task Force Recommendation Statement. Pediatrics 2009 123 1223-1228